Navigation Links
Rogue Mammary Stem Cells Could Hold Key To Breast Cancer Relapse

A new study published in today's issue of the journal Nature says that a team of Australian researchers led by Jane Visvader, of the Walter and Eliza Hall Institute in Melbourne have successfully // isolated a stem cell from the breast pads in female mice that could hold the key to future breast cancer treatments and reconstructive surgery.

The Australian research says that recurrences of breast cancer are triggered by a group of "rogue mammary stem cells" that escape chemotherapy and lie dormant. After a while, these viable stem cells reseed tumors so that a relapse occurs. The authors say that this could prove to be a valuable insight into the treatment of breast cancer if these findings applied to human breast tissue as well. In such a scenario, it could be possible to grow new breast tissue using these stem cells and could prove to be a blessing to women who undergo mastectomy or complete breast removal for their tumors. Researchers postulate that these mammary stem cells could also trigger the development of certain types of breast cancers if they have genetic errors. Stem cells which do carry cancer causing mutations are resistant to chemotherapy, which targets rapidly cells. “The ultimate objective is to create a drug that will, in effect, switch off breast cancer cells,” Dr Visvader commented. “To do this, the exact make-up of genes expressed by normal and rogue stem cells will need to be determined. Then a drug will be designed to engage with and neutralize the faulty feature of the stem cell.” Her team is now examining human breast tissue to see if there are any shared characteristics with the mouse mode.
'"/>




Page: 1

Related medicine news :

1. Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias
2. Blood Cells Capable of Regenerating Liver
3. White Cells Count Can Predict Heart Attack Death Risk
4. Gene Therapy Destroys Pancreatic Cancer Cells
5. Stem Cells Have Few Mutations
6. Heart may pull Cells from Body to Self-repair
7. Cells critical for asthma development found
8. Vitamin D Wipes out Cancer Cells
9. Bone Marrow Cells Help Heart Attack Patients
10. Islet Cells May Lead to Diabetes CureChildren
11. Stem Cells Found To Offer Promise For Hair Growth

Post Your Comments:
(Date:11/23/2009)...ering from women,s hair loss for almost ten years,...sharing her progress and the secret behind her suc...ease of her video diaries which include a direct c...ent. , (PRWeb UK) Novembe...tt Siklosi has released the video diaries that doc...
(Date:11/23/2009)...e-FirstCall/--InfoLogix,Inc.(Nasdaq: IFLG ),aleadi...orthehealthcareandcommercialindustries,announcedto...atSiemensHealthServices,hasjoinedInfoLogixasVicePr... http://www.newscom.com/cgi-bin/prnh/20090618/NE35...reServicesforInfoLogix,Mr.Waywillberesponsiblefort...
(Date:11/23/2009)...and survivors treated with chemotherapy suffer ins... conditions, hindering patients, ability to fully ... of Rochester Medical Center. , A study of 823 c...les at nearly three times the rate of the general ...ger patients and those with lung and breast cancer...
(Date:11/23/2009)...3 percent with moderate-to-high intensity workouts... Moderate-to-high intensity exercise such as joggi... in older men but not in women, researchers report...en, average age 69, in Manhattan who were followed...e 238 strokes among the participants. At the start...
(Date:11/23/2009)...pproval process in United States, researcher says ...Problems with the popular arthritis drug Vioxx, in...d death, were known for years before the drug,s vo...report says. , Contrary to claims by the manuf...ere evident in 2000, a year after the drug was put...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4
...efree Senior Living,Press, based in Santa Barbara,...author and Alzheimer,s care professional John G. B...We Do Now? Families Facing Alzheimer,s,",offers pr...n the diagnosis of Alzheimer,s impacts their lives...
...cation to help overweight students reach ...ct. 27 Bags of Halloween candy are piled,high in ...s temptation for,those battling obesity. For the p... San Diego State University Exercise and Nutrition...
...urs instruction, likely affecting patients, quit r...-- Few doctors or other health-care providers have...atients quit smoking, a U.S. study suggests. , It ...than 6 percent know the U.S. Agency for Healthcare...
...ous atrial fibrillation, review finds, , ,...one-building medications known as bisphosphonates ... , A review of available research concludes that t...strokes. , "In addition to possible gastrointestin...
...Chairman of the Board, BRAINTREE, Mass., Oct. 27 ...n Concannon will be promoted to the,position of Pr...g Brad,Nutter in this role. Brian will also join t...of the Company as,Executive Chairman of the Haemon...
...alize, better analyze reams of electronic medica... healthcare, BIRMING...www.teksouth.com ), a veteran systems integrator p...st phase of a program,that may ultimately enable b...
Other Medicine News:Health News:Alzheimer's Strikes Every 71 Seconds! Carefree Senior Living Press Releases New Book: 'What the Heck Do We Do Now? Families Facing Alzheimer's' 2Health News:Supersized P.E.: Ten Tips to Help Overweight Kids Get Healthy 2Health News:Supersized P.E.: Ten Tips to Help Overweight Kids Get Healthy 3Health News:Supersized P.E.: Ten Tips to Help Overweight Kids Get Healthy 4Health News:Doctors Lack Smoking Cessation Training 2Health News:Osteoporosis Meds Linked to Heart Problem 2Health News:Osteoporosis Meds Linked to Heart Problem 3Health News:Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009 2Health News:Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009 3Health News:Teksouth Awarded $100,000 Defense Department Grant in First Phase of Medical Data Integration Project 2
(Date:11/23/2009)...,, EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsRe...(TM): Feraheme report,thesecondinamulti-phasesyn...G,snewIVironproduct,Feraheme,throughthefirstsixmon...esquantitativeinformationfrom50uniqueNephrologists...sassesstrialanduseofFeraheme,obstaclestouse,reason...
(Date:11/23/2009)...,, FORTWORTH,Texas,Nov.23/PRNewswire-FirstCa...Board:WNDM)arapidlygrowingproviderofspecialtymedic...lresultsandhasprovidedacomprehensivemanagementbusi...calendaryear. ,, Q32009salesincreased33.5%to$1...quityasoftheQ32009increasedto$3,327,892vs.Q32008sh...
(Date:11/23/2009)...,, INDIANAPOLIS,Nov.23/PRNewswire/--AMDLASER...itmenttodentaleducationbypartneringwithprestigious...age.Picasso,byAMDLASERS,willbetheexclusivesofttiss...ctivities,whicharetargetedtothetop2%ofdentists. ,...090414/DE98219 ) ,, "ItiswithgreatpleasurethatI...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Nestle 28R 29 TOLL HOUSE 28R 29 Refrigerated Cookie Dough Recall Update July 9 2009 51287 1Nestle 28R 29 TOLL HOUSE 28R 29 Refrigerated Cookie Dough Recall Update July 9 2009 51287 22 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 12 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 22 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 32 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 4RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 1RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 2
... 48-week boceprevir-based ...eported for 28-week boceprevir arm, KENILWORTH, N...GP ) today reported top-line results from a planne...ir, its investigational,oral hepatitis C protease ...ained virologic response (SVR) in patients receivi...
...anofi,Pasteur, the vaccines division of sanofi-ave...one(R), Influenza Virus Vaccine) in the United,Sta...n doses of influenza,vaccine began shipping this w... formulation by the U.S. Food and Drug Administrat... health-care providers and to the Centers for,Dise...
Other Medicine Technology:Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 5
Dual Flatscreen Monitor Mounts (with Skytron Surgical Lights)
...T® is an interventional guidance device that u...racy of computed tomography (CT)-guided puncture p...liCT® also has the potential to increase the t...ng biopsies and fluid drainage, and minimize patie...
UltraBright™ Diode
...ith AAA Endovascular Graft with the H&L-B One-Shot...ndicated for the endovascular treatment of patient...aving morphology suitable for endovascular repair....ced within an aneurysm to "seal off" the aneurysm....
Medicine Products: